GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (NYSE:GSK) » Definitions » Additional Paid-In Capital
中文

GSK (GSK) Additional Paid-In Capital : $4,368 Mil(As of Dec. 2023)


View and export this data going back to 1987. Start your Free Trial

What is GSK Additional Paid-In Capital?


GSK's quarterly additional paid-in capital declined from Jun. 2023 ($4,356 Mil) to Sep. 2023 ($4,270 Mil) but then increased from Sep. 2023 ($4,270 Mil) to Dec. 2023 ($4,368 Mil).

GSK's annual additional paid-in capital declined from Dec. 2021 ($4,390 Mil) to Dec. 2022 ($4,190 Mil) but then increased from Dec. 2022 ($4,190 Mil) to Dec. 2023 ($4,368 Mil).

GSK Additional Paid-In Capital Historical Data

The historical data trend for GSK's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK Additional Paid-In Capital Chart

GSK Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,159.90 4,409.95 4,389.63 4,190.01 4,368.35

GSK Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,190.01 4,185.68 4,356.06 4,269.80 4,368.35

GSK Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

GSK Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of GSK's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

GSK (GSK) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (NYSE:GSK) » Definitions » Additional Paid-In Capital
Comparable Companies
LSE:AZN LLY JNJ MRK ABBV XSWX:ROG XSWX:NOVN PFE AMGN XPAR:SAN BMY GILD TSE:4519 TSE:4568 SHSE:600276 BIIB XTER:BAYN TSE:4578 SHSE:600436 TSE:4503
Traded in Other Exchanges
GLAXF:USA GSK N:Mexico GSKl:UK GSK:UK GS71:Germany GS70:Germany GS71:Germany GS70:Germany GS71:Germany G1SK34:Brazil GSK:Argentina
Address
980 Great West Road, Brentford, Middlesex, GBR, TW8 9GS
Website
https://www.gsk.com
In the pharmaceutical industry, GSK ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.